COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY. RMSR [Internet]. 2025 Jun. 4 [cited 2025 Aug. 6];3(6):94-100. Available from: https://medscireview.net/index.php/Journal/article/view/1284